NCT06110754Recruiting

Development and Adaptation of I-STRONG for SCD

Name: Clinical Trial NCT06110754
Creator: Emory University
Keywords: Sickle Cell Disease, I-STRONG for SCD, behavioral, clinical trial, United States of America

Integrative Training Program for Pediatric Sickle Cell Pain: Development and Adaptation of I-STRONG for SCD

Emory UniversityClinicalTrials.govbehavioral

Verified

Study focus

Disease/Condition: Sickle Cell Disease
Drug/Device/Intervention: I-STRONG for SCD
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Emory University
Location: Atlanta,Cincinnati, United States of America

Timeline & enrollment

Phase: N/A
Start date: Oct 24, 2023
End date: Sep 30, 2024
Enrollment: 12 participants

Primary outcome

Change in Brief Pain Inventory (BPI) Pain Severity Score

Summary

This study develops and tests the feasibility and acceptability of an adapted intervention, Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle cell disease.

ICD-10 classifications

Sickle-cell disordersOther sickle-cell disordersSickle-cell traitSickle-cell anaemia with crisisSickle-cell anaemia without crisis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06110754
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06110754 through Pure Global AI's free database. This phase not specified trial is sponsored by Emory University and is currently Recruiting. The study focuses on Sickle Cell Disease. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.